Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Current Medicinal Chemistry|September 15, 2009
Methionine-derived metabolites in apoptosis: therapeutic opportunities for inhibitors of their metabolism in chemoresistant cancer cellsGérard Quash, Guy FournetBiochemical Pharmacology|August 9, 2003
Anaplerotic reactions in tumour proliferation and apoptosisGerard Quash, Guy Fournet, Uwe ReichertEuropean Journal of Medicinal Chemistry|February 18, 2014
New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studiesCharlène Sagnes, Guy Fournet, Grzegorz Satala, et al.Nuclear Medicine and Biology|July 2, 2003
Carbon-11 labelling of 8[[3-[4-(2-[(11)C]methoxyphenyl)piperazin-1-yl]-2-hydroxypropyl]oxy]thiochroman, a presynaptic 5-HT(1A) receptor agonist, and its in vivo evaluation in anaesthetised rat and in awake catLuc Zimmer, Guy Fournet, Joseph Benoît, et al.European Journal of Medicinal Chemistry|July 8, 2014
Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitorsAurélien Putey, Guy Fournet, Olivier Lozach, et al.Bioorganic Chemistry|January 3, 2006
Synthesis and effects of 3-methylthiopropanoyl thiolesters of lipoic acid, methional metabolite mimicsCeline Courvoisier, Marie Julie Paret, Jacqueline Chantepie, et al.Chemical Science|April 25, 2019
Monodisperse polysarcosine-based highly-loaded antibody-drug conjugatesWarren Viricel, Guy Fournet, Sabine Beaumel, et al.Journal of Immunological Methods|September 8, 2004
Definition of the fine specificity of the monoclonal antibody 81D4: its reactivity with lysine and polyamine isopeptide cross-linksVincent Thomas, Guy Fournet, Frantz Simonet, et al.Biochemical Pharmacology|September 18, 2002
Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1): restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF(3) cells overexpressing bcl(2)Gerard Quash, Guy Fournet, Jacqueline Chantepie, et al.Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker PlatformLouise Conilh, Guy Fournet, Eric Fourmaux, et al.Pageof 3